|
Recent Advance and Challenges in Molecular Targeted Therapy for Cancers--引言
|
|
Overview of Molecular Targeted Therapy in Oncology
|
|
Reimbursement for Molecular Targeted Therapy of Cancer Patients -- Will There be A Solution?
|
|
Recent Advance in Target Therapy in Rheumatic Diseases--引言
|
|
TNF-a Target Therapy
|
|
B cell Target Therapy
|
|
Co-stimulatory Molecule Target Therapy
|
|
Novel Cytokine/Cytokine Receptor Target Therapy
|
|
治療血脂異常的新進展--引言
|
|
Optimizing CVD Prevention: LDL-C Lowering and HDL-C Elevation
|
|
Holy Grail or Double Edged Blade: Statins for Hyperlipidemia, CVD and Cancer
|
|
敗血症治療新進展--引言
|
|
敗血症治療新進展
|
|
早期消化道癌症之診治新進展--引言
|
|
早期胃癌之內視鏡診斷
|
|
早期胃癌之內視鏡治療
|
|
早期胃癌之病理診斷
|
|
Recent Advance in Multidetector Coronary Angiography--引言
|
|
Recent Advance of MDCT
|
|
How to apply MDCT in Clinical Practice?
|
|
MDCT, Thallium 201 Perfusion Scan, Stress Echocardiography, Which is Better?
|
|
睡眠呼吸障礙之診治新進展--引言
|
|
在睡眠呼吸終止症患者中陽壓呼吸器效果的預測與評估
|
|
耳鼻喉科評估與睡眠呼吸終止相關性
|
|
下顎位置影響口咽軟組織於呼吸時之行為
|
|
Recent Advance in IgE and Anti-IgE for Internal Medicine Doctors: Past, Present, and Future--引言
|
|
IgE and Anti-IgE:Past, Present and Future
|
|
Anti-IgE in Bronchial Asthma
|
|
Recent Advance in Cell Therapy in Hematology--引言
|
|
Adoptive Cellular Immunotherapy in Leukemia and Hematopoietic Stem Cell Transplantation
|
|
Adoptive Cellular Immunotherapy in Viral Infection
|
|
Graft Versus Tumor Effects in the Treatment of Hematological Malignancies
|
|
The role of Mesenchymal Stem Cells in the Treatment of Hematological Diseases
|
|
Recent Advance in Allergen Immunotherapy: Injection, Sublingual or Food?--引言
|
|
口服耐受性與免疫療法
|
|
舌下減敏療法
|
|
免疫療法介紹(包括注射)
|
|
Recent Advance in Drug Eluting Stents--引言
|
|
Limus-Eluting Stents(Cypher, Endeavor, Xience V)
|
|
Paclitaxel-Eluting Stents(Taxus etc), and Issue of DES Thrombosis
|
|
Next Generation DES(Genous, Biodegradable, Bioabsorable Stents)
|
|
糖尿病用藥的新進展--引言
|
|
Current anti-diabetic therapy in Taiwan
|
|
GLP-1:an alternative approach for type 2 DM
|
|
Shifts in Treatment Paradigms of Type 2 Diabetes: Incretin Enhancers are Coming
|